Figure S1. Pharmacological profile of the voltage-dependent barium current of POMC neurons (related to Figure 1).
(A) Representative Ba 2+ currents in the presence and absence of CdCl2 (100 µM, where indicated) evoked by voltage-steps (-100 to 0 mV, 50 ms duration) from POMC neurons in intact slices (B) Diary plot of barium current against time following the attainment of the whole-cell configuration (mean ± SEM, n = 10).
(C) Ba 2+ currents were evoked in the presence and absence of selective calcium channel antagonists, as denoted by the diary plots (left) and examples of steady-state currents (right). Control (black) currents were partially blocked by mibefradil (10 µM, dark blue), w-conotoxin GVIA (200 nM, green) and nimodipine (10 µM, yellow).
(D) In the constant presence of mibefradil, w-conotoxin GVIA and nimodipine (open circles and black corresponding trace), w-agatoxin IVA (200 nM, red) further reduced the Ba 2+ current amplitude, although a current, resistant to this cocktail of blockers, remained.
(E) Bar chart, showing the mean magnitude of Ba 2+ current in the absence of blockers (a), sensitive to inhibition by the various calcium channel antagonists (b -e) and resistant to block (f), (mean ± SEM, n = 5 -7).
(F) Representative diary plot (left) and current trace (right) of Ba 2+ currents evoked at 0 mV in the presence and absence of SNX-482 (50 nM).
(G) Representative Ba 2+ currents from dispersed POMC neurons evoked at -50 mV following a 5 s duration steady-state inactivation protocol (-100 to -50 mV in 10 mV steps). Currents are shown in the absence (black) and presence (grey) of leptin (50 nM).
(H) Steady-state inactivation for currents evoked by the protocol described in (I), in the absence (closed circles) and presence (open circles) of leptin. Data points (mean ± SEM, n = 4) were best fit with the Boltzmann equation.
